Bird & Bird advises Precision Medicine Group on the acquisition of Epiontis

Bird & Bird LLP advises Precision Medicine Group, a scientific services company helping life science innovators develop medical products, on the acquisition of all shares in Epiontis GmbH, a leading immune monitoring and epigenetic technology service provider based in Berlin.

The acquisition will allow Precision for Medicine to expand on its immune monitoring capabilities with Epiontis’s epigenetic technology, and strengthen its global footprint in the rapidly expanding precision medicine sector. 

The Bird & Bird team advised Precision for Medicine on the due diligence, signing and closing of the transaction, including IP patent due diligence and regulatory advice regarding  the life sciences aspects of the deal. 

Stefan Münch (Corporate/M&A, Munich) led the transaction on the German law aspects, assisted by counsel Stephan Kübler and associates Michael Gassner and Benedikt Weiss (both Corporate/M&A, Munich), partner Ralph Panzer and associate Julia Gottinger (both Employment, Munich), counsel Gerrit Wiedow (Employment, Hamburg), partners Michael Alt, Christopher Maierhöfer and associate Marie-Theres Schmid (all Patents, Munich), partner Markus Körner and counsel Thomas Urband (both Trademarks, Munich), partner Alexander Csaki and associate Clarissa Junge-Gierse (both Life Sciences/Regulatory, Munich) and partner Michael Jünemann (Finance, Frankfurt). Bird & Bird London partner Ali Ramadan and associate Hannah Fletcher (both Corporate/M&A, London) also assisted on the UK law issues. Legal in-house advisors were General Counsel John Mariano and Senior Counsel Rita Khoobchandani.

News & Deals

More News & Deals

News

Bird & Bird continues sponsoring Slush Investor Day, reinforcing commitment to Nordic tech investment

Sep 13 2024

Read More

News

Bird & Bird’s Aviation team in Asia-Pacific ranks 2nd in AFG Legal Survey

Sep 12 2024

Read More

Deal

Bird & Bird has advised East Japan Railway Company in the sale of Decorum Vending Limited

Sep 11 2024

Read More

Deal

Bird & Bird advised Capital Croissance on its investment in Aether FS

Sep 09 2024

Read More

Deal

Bird & Bird acts as sell-side legal advisor to Vitruvian Partners on its sale of Benify

Sep 06 2024

Read More

Deal

Bird & Bird advise Leo Capital on launching their first Nordic Fund

Sep 05 2024

Read More

Related capabilities